Bleeding News and Research

RSS

African-American women who reported childhood abuse had greater risk of uterine fibroids

According to a new study from the Slone Epidemiology Center (SEC) at Boston University, African-American women who reported sexual or physical abuse before age 11 had a greater risk of uterine fibroids in adulthood compared with women who had no such abuse history.

25 Jan 2013

Neuromuscular blockade (NMB) reversal

General anesthesia is made up of three components: hypnotic medicines, to induce sleep; analgesics, or medicines to inhibit pain; and NMB agents that induce muscle relaxation. Anesthesiology professionals use NMB to relax a patient’s muscles and prevent involuntary movement that could impact surgery.

24 Jan 2013

Inspiration, Ipsen and Baxter enter Asset Purchase Agreement for OBI-1

Ipsen and Inspiration Biopharmaceuticals Inc. today announced they entered into an Asset Purchase Agreement (APA) whereby Baxter International (Baxter) agrees to acquire the worldwide rights to OBI-1, a recombinant porcine factor VIII (rpFVIII) in development for congenital hemophilia A with inhibitors and acquired hemophilia A, and Ipsen's industrial facility in Milford (Boston, MA).

24 Jan 2013

Covidien’s EverFlex stent with Entrust delivery system receives CE Mark

Covidien, a leading global provider of healthcare products, today announced CE Mark approval for its EverFlex Self-expanding Peripheral Stent with Entrust Delivery System.

23 Jan 2013

Psychiatrist claims medical marijuana dangerous for treatment of psychiatric problems

Using medical marijuana to treat conditions such as anxiety and depression is dangerous and has no basis in medical science, says Dr. Timothy R. Jennings, a prominent Tennessee psychiatrist and consultant to The Center for Counseling and Health Resources in Edmonds, WA.

22 Jan 2013

Biophysical Society Annual Meeting to highlight innovations in medicine, physics, and more

Honeybee silk-inspired materials; a deconstruction of the Ebola virus; how microbes evolve resistance to antibiotics; and a possible connection between Alzheimer's disease and type II diabetes are just some of the intriguing topics that will be presented at the 57th Annual Meeting of the Biophysical Society (BPS).

22 Jan 2013

Bevacizumab QoL impact highlighted in ovarian cancer patients

The ICON7 study results suggest that improved progression-free survival with bevacizumab therapy for high-risk ovarian cancer may come at the cost of health-related quality of life.

21 Jan 2013

Checklists can help surgical teams perform better during emergencies

When doctors, nurses and other hospital operating room staff follow a written safety checklist to respond when a patient experiences cardiac arrest, severe allergic reaction, bleeding followed by an irregular heart beat or other crisis during surgery, they are nearly 75 percent less likely to miss a critical clinical step, according to a new study funded by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality.

19 Jan 2013

St. Jude Medical’s AMPLATZER Amulet device receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its AMPLATZER Amulet Left Atrial Appendage Occluder.

19 Jan 2013

Calcium receptor – potential drug target for sleeping sickness

While its common name may make it sound almost whimsical, sleeping sickness, or African trypanosomiasis, is in reality a potentially fatal parasitic infection that has ravaged populations in sub-Saharan Africa for decades, and it continues to infect thousands of people every year.

19 Jan 2013

ECLS system supports flu patients in their recovery from severe respiratory problems

In recent weeks the intensive critical care units at University Health Network's Toronto General Hospital have used Extra Corporeal Lung Support (ECLS) to support five influenza (flu) patients in their recovery from severe respiratory problems.

19 Jan 2013

Penn Medicine to establish new center for treatment and research of blood diseases

Penn Medicine will establish the Philadelphia region's first dedicated center for the treatment and research of blood diseases by combining the expertise of physicians who specialize in the care of blood disorder patients of all ages along with basic science and clinical researchers who are working to advance treatments for these illnesses.

18 Jan 2013

Macular pigment screening: an interview with Jaquie Finn, Product Line Manager at Elektron Technology

AMD is the leading cause of vision loss in anyone over 50 and globally in 2010 it was estimated to cost $340 billion to treat AMD. The costs are set to spiral over the next 20 years and really over burden the healthcare system unless people start to take preventative action.

18 Jan 2013

Researchers: Operating room checklists, good work environments for nurses help reduce errors, readmissions

Having step-by-step checklists on hand may help doctors and nurses manage emergencies in the operating room, a new study suggests. In situations when a person's heart stops beating on the operating table or a patient begins bleeding uncontrollably, those lists can save time and brainpower, researchers said.

18 Jan 2013

Intermountain Risk Score tool can predict mortality among trauma patients

A simple, inexpensive blood test performed on trauma patients upon admission can help doctors easily identify patients at greatest risk of death, according to a new study by researchers at Intermountain Medical Center in Salt Lake City.

18 Jan 2013

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.

18 Jan 2013

Prevention opportunity for postoperative cardiac arrest

Postoperative complications occur in more than three-quarters of patients who have a cardiac arrest, shows research that suggests an opportunity for intervention.

17 Jan 2013

FDA approves InfraScan’s noninvasive handheld brain hematoma detector

InfraScan, a medical device company specializing in brain injury diagnostic products, announced today that it has obtained U.S. Food and Drug Administration approval to market the Infrascanner Model 2000, a noninvasive handheld brain hematoma detector.

17 Jan 2013

Study finds primary factors that increase risk of mortality in subarachnoid haemorrhage survivors

"It is particularly important for subarachnoid haemorrhage survivors to refrain from smoking and to take care of their blood pressure and cholesterol levels; apart from age, these are the primary factors behind the increased risk of mortality," explains neurosurgeon Miikka Korja from the HUCH's Neurosurgery Department together with professor Jaakko Kaprio from the University of Helsinki's Hjelt Institute.

16 Jan 2013

FDA approves Santarus’ UCERIS for induction of remission in patients with ulcerative colitis

Santarus, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved UCERIS (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis.

16 Jan 2013

Bleeding News and Research

African-American women who reported childhood abuse had greater risk of uterine fibroids

Neuromuscular blockade (NMB) reversal

Inspiration, Ipsen and Baxter enter Asset Purchase Agreement for OBI-1

Covidien’s EverFlex stent with Entrust delivery system receives CE Mark

Psychiatrist claims medical marijuana dangerous for treatment of psychiatric problems

Biophysical Society Annual Meeting to highlight innovations in medicine, physics, and more

Bevacizumab QoL impact highlighted in ovarian cancer patients

Checklists can help surgical teams perform better during emergencies

St. Jude Medical’s AMPLATZER Amulet device receives European CE Mark approval

Calcium receptor – potential drug target for sleeping sickness

ECLS system supports flu patients in their recovery from severe respiratory problems

Penn Medicine to establish new center for treatment and research of blood diseases

Macular pigment screening: an interview with Jaquie Finn, Product Line Manager at Elektron Technology

Researchers: Operating room checklists, good work environments for nurses help reduce errors, readmissions

Intermountain Risk Score tool can predict mortality among trauma patients

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

Prevention opportunity for postoperative cardiac arrest

FDA approves InfraScan’s noninvasive handheld brain hematoma detector

Study finds primary factors that increase risk of mortality in subarachnoid haemorrhage survivors

FDA approves Santarus’ UCERIS for induction of remission in patients with ulcerative colitis

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News